Asthma Clinical Trial Results

Browse clinical trials for Asthma by phase, sponsor and reported results. Data from ClinicalTrials.gov.

• A Study of Remote Asthma Management Using an Integrated Artificial Intelligence-assisted EHR Dashboard and Mob
  N/A · Mayo Clinic · Completed · Jul 22, 2026
• Developing a Childhood Asthma Risk Passive Digital Marker
  N/A · Indiana University · Terminated · Jul 21, 2026
• A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg To
  Phase 3 · Chiesi Farmaceutici S.p.A. · Completed · Sep 4, 2025
• A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
  Phase 3 · Hoffmann-La Roche · Completed · Jul 17, 2026
• A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Seco
  Phase 3 · Hoffmann-La Roche · Completed · Jul 17, 2026
• Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the Un
  Phase 4 · AstraZeneca · Completed · Jul 16, 2026
• Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma
  Phase 2 · ARS Pharmaceuticals, Inc. · Completed · Jul 14, 2026
• Severe Asthma, MepolizumaB and Affect: SAMBA Study
  N/A · University Hospital Southampton NHS Foundation Trust · Completed · Jul 13, 2026
• Sub-Sensitivity to Long-Acting Bronchodilators (LABA)
  N/A · National Jewish Health · Completed · Jul 6, 2026
• Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)
  Phase 3 · AstraZeneca · Completed · Jul 2, 2026
• A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids
  Phase 3 · Hoffmann-La Roche · Terminated · Jun 30, 2026
• Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)
  Phase 3 · AstraZeneca · Completed · Jun 30, 2026
• Examining Changes in Nasal IL-1 During Acute Asthma Exacerbation in Adolescents
  N/A · University of North Carolina, Chapel Hill · Completed · Jun 29, 2026
• TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)
  Phase 3 · Chiesi Farmaceutici S.p.A. · Completed · May 29, 2026
• TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABA
  Phase 3 · Chiesi Farmaceutici S.p.A. · Completed · Jun 26, 2026

Trials by condition

Lung CancerNon-Small Cell Lung CancerBreast CancerColorectal CancerGastric CancerLiver CancerPancreatic CancerProstate CancerOvarian CancerMelanomaLeukemiaLymphomaMultiple MyelomaGlioblastomaType 2 DiabetesObesityHypertensionHeart FailureAtrial FibrillationStrokeChronic Kidney DiseaseNASH / MASHAlzheimer’s DiseaseParkinson’s DiseaseMultiple SclerosisDepressionEpilepsyALSRheumatoid ArthritisPsoriasisAtopic DermatitisCrohn’s DiseaseUlcerative ColitisLupusAsthmaCOPD

All trials